ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice

被引:54
作者
Kronqvist, P
Kawaguchi, N
Albrechtsen, R
Xu, XF
Schroder, HD
Moghadaszadeh, B
Nielsen, FC
Fröhlich, C
Engvall, E
Wewer, UM
机构
[1] Univ Copenhagen, Inst Mol Pathol, DK-2100 Copenhagen, Denmark
[2] Burnham Inst, La Jolla, CA 92037 USA
[3] Odense Univ, Dept Pathol, Odense, Denmark
[4] Copenhagen Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark
基金
美国国家卫生研究院; 日本学术振兴会;
关键词
D O I
10.1016/S0002-9440(10)64431-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Muscular dystrophy is characterized by muscle degeneration and insufficient regeneration and replacement of muscle fibers by connective tissue. New therapeutic strategies directed toward various forms of muscular dystrophy are needed to preserve muscle mass and promote regeneration. in this study we examined the role of the transmembrane ADAM12, a disintegrin and metalloprotease, which is normally associated with development and regeneration of skeletal muscle. We demonstrate that ADAM12 overexpression in the dystrophin-deficient mdx mice alleviated the muscle pathology in these animals, as evidenced by less muscle cell necrosis and inflammation, lower levels of serum creatine kinase, and less uptake of Evans Blue dye into muscle fibers. These studies demonstrate that ADAM12 directly or indirectly contributes to muscle cell regeneration, stability, and survival.
引用
收藏
页码:1535 / 1540
页数:6
相关论文
共 41 条
  • [1] Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy
    Anderson, JE
    Weber, M
    Vargas, C
    [J]. CELL TRANSPLANTATION, 2000, 9 (04) : 551 - 564
  • [2] Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
    Asakura, M
    Kitakaze, M
    Takashima, S
    Liao, Y
    Ishikura, F
    Yoshinaka, T
    Ohmoto, H
    Node, K
    Yoshino, K
    Ishiguro, H
    Asanuma, H
    Sanada, S
    Matsumura, Y
    Takeda, H
    Beppu, S
    Tada, M
    Hori, M
    Higashiyama, S
    [J]. NATURE MEDICINE, 2002, 8 (01) : 35 - 40
  • [3] Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
    Barton, ER
    Morris, L
    Musaro, A
    Rosenthal, N
    Sweeney, HL
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 157 (01) : 137 - 147
  • [4] Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
    Barton-Davis, ER
    Cordier, L
    Shoturma, DI
    Leland, SE
    Sweeney, HL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) : 375 - 381
  • [5] ADAMs: focus on the protease domain
    Black, RA
    White, JM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) : 654 - 659
  • [6] Remarkable roles of proteolysis on and beyond the cell surface
    Blobel, CP
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (05) : 606 - 612
  • [7] Analysis for transcript expression of meltrin α in normal, regenerating, and denervated rat muscle
    Bornemann, A
    Kuschel, R
    Fujisawa-Sehara, A
    [J]. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2000, 21 (05) : 475 - 480
  • [8] Enhanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice
    Burkin, DJ
    Wallace, GQ
    Nicol, KJ
    Kaufman, DJ
    Kaufman, SJ
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 152 (06) : 1207 - 1218
  • [9] Muscular dystrophy - Reason for optimism?
    Burton, EA
    Davies, KE
    [J]. CELL, 2002, 108 (01) : 5 - 8
  • [10] Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO